Creative Medical Technology Holdings, Inc. CELZ · Stock Open Creative Medical Technology Holdings, Inc. in new tab
Creative Medical Technology Holdings, Inc. Analysis (CELZ)
Is Creative Medical Technology Holdings, Inc. a good investment? Creative Medical Technology Holdings, Inc. (CELZ) is currently trading at 0.7400 USD.
Earnings Schedule: Creative Medical Technology Holdings, Inc. is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is -0.88.
Investor FAQ
Does Creative Medical Technology Holdings, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Creative Medical Technology Holdings, Inc.?
Creative Medical Technology Holdings, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of -2.07.
Company Profile
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
| Split Date | Split Ratio to 1 |
|---|---|
| Feb. 3, 2020 | 1:100 |
| Nov. 10, 2021 | Needs review |
| June 12, 2023 | 1:10 |
Community Discussion